Principal Financial Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,977
| Closed | -$297K | – | 2393 |
|
|
2024
Q1 | $297K | Buy |
17,977
+108
| +0.6% | +$1.78K | ﹤0.01% | 2089 |
|
|
2023
Q4 | $261K | Buy |
17,869
+88
| +0.5% | +$1.29K | ﹤0.01% | 2097 |
|
|
2023
Q3 | $218K | Buy |
17,781
+1,569
| +10% | +$19.3K | ﹤0.01% | 2140 |
|
|
2023
Q2 | $194K | Buy |
16,212
+2,499
| +18% | +$29.8K | ﹤0.01% | 2190 |
|
|
2023
Q1 | $183K | Buy |
13,713
+685
| +5% | +$9.16K | ﹤0.01% | 2197 |
|
|
2022
Q4 | $280K | Buy |
+13,028
| New | +$280K | ﹤0.01% | 2122 |
|